Tenoxicam

from this book:
Book cover

Mechanism of Action

Tenoxicam inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and providing long-acting anti-inflammatory, analgesic, and antipyretic therapeutic effects.

Indications

  • Treats painful osteoarthritis inflammatory symptoms.
  • Manages rheumatoid arthritis chronic inflammation.
  • Reduces ankylosing spondylitis persistent pain.
  • Used for acute musculoskeletal pain.
  • Provides prolonged anti-inflammatory therapeutic relief.

Contra-indications

  • Avoid with active gastrointestinal bleeding.
  • Contraindicated in severe renal impairment.
  • Avoid after prior NSAID anaphylaxis.
  • Contraindicated during coronary bypass surgery.
  • Avoid with advanced hepatic failure.

Doses

Adult dose 20 mg once daily, short-term for acute conditions; lowest effective dose for chronic use.
Pediatric dose Not recommended for children; safety and efficacy not established.

Forms

Form Strength
Tablet 20 mg
Powder for injection 20 mg vial

Side Effects

  • Causes abdominal pain and dyspepsia.
  • May induce nausea and vomiting.
  • Increases gastrointestinal bleeding ulcer risk.
  • Can trigger dizziness and headache.
  • Causes fluid retention and edema.
  • May elevate blood pressure significantly.
  • Potentially impairs kidney function progressively.
  • Can cause photosensitivity and rash.

Drug Interactions

  • Warfarin increases dangerous bleeding risk.
  • ACE inhibitors reduce antihypertensive effectiveness.
  • Diuretics may lose intended efficacy.
  • Lithium levels may rise dangerously.
  • Methotrexate toxicity risk increases greatly.
  • SSRIs heighten gastrointestinal bleeding risk.
  • Aspirin reduces tenoxicam anti-inflammatory potency.
  • Cyclosporine increases nephrotoxicity risk markedly.

Usage for Pregnancy

×
Avoid, especially third trimester
(ductus arteriosus closure and oligohydramnios risk).

Usage for Breast Feeding

!
Use with caution; limited data, possible infant GI/kidney effects.

Trade Names

Commonly reported trade names containing tenoxicam. Availability, formulation and registration can vary by country and over time.

Egyptian market examples International examples Tenoxicam 20 mg
Trade name Market / region Reported form / strength Manufacturer / note
EpicotilEgypt20 mg film-coated tablets; 20 mg injection vial; 20 mg suppositoryEIPICO
SoralEgypt / regional20 mg capsules; 20 mg suppository; 20 mg/2 mL injectionGlobal Napi Pharmaceuticals
AnoxicamEgypt20 mg tablets; 20 mg suppositoryMarcyrl
TenocamEgypt20 mg capsules; 20 mg suppositoryKahira
TenoxilEgypt20 mg tablet; 20 mg vialEgyptian market listing
SerelanocamEgypt20 mg film-coated tabletsUnipharma Co.
TenoxicamEgypt20 mg capsulesGeneric product listing
TilcotilInternational / Europe20 mg tabletsNationally authorised in multiple markets
DolmenEurope20 mg tablet; injectable formulationEuropean product listing
DoxicanPortugal20 mg/2 mL powder + solvent for injectionLaboratórios Azevedos
TilcitinGreeceTenoxicam productNational authorisation listing
TilconoxBulgariaTenoxicam productTchaikapharma
ToscacalmGreeceTenoxicam productGenepharm
TenalginInternational20 mg film-coated tabletTenoxicam brand listing
ArtriunicInternational20 mg tabletTenoxicam brand listing
RodixInternational20 mg powder for injectionTenoxicam brand listing
TecamInternational20 mg tabletTenoxicam brand listing
InflagelInternational20 mg suppositoryTenoxicam brand listing
Neo EndusixInternational20 mg powder + solvent for injectionTenoxicam brand listing
Tenoxicam MylanEuropeTenoxicam productMylan
Tenoxicam SandozEuropeTenoxicam productSandoz
Tenoxicam EMSInternational20 mg tabletEMS
Tenoxicam AA PharmaInternational20 mg tabletAA Pharma
Tenoxicam BestpharmaInternational20 mg tabletBestpharma

Pharmacist Tips

  • Monitor renal function
  • Avoid gastrointestinal bleeding
  • Take with food
  • Contraindicated active ulcer
Trade-name availability is market-specific and may change. Keep local registration data updated when this page is used in a published drug reference.